Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating elafibranor for primary biliary cholangitis in patients with inadequate response to ursodeoxycholic acid has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Genfit | Conditions: Primary Biliary Cholangitis (PBC) | Phase 2 | Status: COMPLETED | Results posted: 2019-09-24